Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
TSX:VPH
Price:
0.105 CAD
-8.7%
Updated:
May 3, 2024
Valeo Pharma Inc
Cash from Investing Activities
|
Valeo Pharma Inc
Cash from Investing Activities Peer Comparison
Comparables:
BHC
TH
K
GUD
EDT
CPH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Cash from Investing Activities
-CA$5.6m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Investing Activities
-$2.1B
|
CAGR 3-Years
-102%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
9%
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash from Investing Activities
$1.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Investing Activities
CA$29.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Cash from Investing Activities
-$144k
|
CAGR 3-Years
43%
|
CAGR 5-Years
64%
|
CAGR 10-Years
-31%
|
See Also
What is Valeo Pharma Inc's Cash from Investing Activities?
Cash from Investing Activities
-5.6m
CAD
-5.6m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Cash from Investing Activities amounts to -5.6m CAD.
What is Valeo Pharma Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-58%
-58%
Over the last year, the Cash from Investing Activities growth was 19%. The average annual Cash from Investing Activities growth rates for Valeo Pharma Inc have been -58% over the past three years .
You don't have any saved screeners yet
